Frontier Medicines is a pre-clinical stage biopharmaceutical company that is focused on discovering and developing breakthrough medicines to treat serious diseases. The company's proprietary chemoproteomic platform enables the discovery of small molecule drugs that can target proteins previously considered undruggable. Frontier Medicines is headquartered in South San Francisco, California and was founded in 2019.